Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » The Latest Developments in Medical Research in the US

    The Latest Developments in Medical Research in the US

    npsnps4 August 2023Updated:4 July 2024
    — Filed under: Focus
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Medical research is a field that has always been important and has always attracted investors, government bodies, and researchers. But as the world continues to look ahead at even better drugs and therapeutics to treat illnesses, for many, the thought of the next pandemic or major health emergency is on their minds. This is where medical research comes into the picture, looking at solutions not just for today but for the future.

    Are you curious about the latest developments in medical research in the US? Here’s a look at some of the latest news.

    mRNA Vaccinology Taking a Front Seat

    There are plenty of medical research developments happening right now, but next-generation mRNA vaccinology has to be one of the top ? if not the most talked about platforms. This can be attributed to the COVID-19 pandemic, as mRNA vaccines became mainstream. They weren’t new technology but never before had they gotten that kind of exposure and use. For many in the medical research fields, it was an exciting step forward for the technology and the door has only just been opened.

    Next-generation mRNA vaccinology is meant to explore its capabilities further and apply it in broad applications. There is focus right now on mRNA vaccines for the Zika virus and cancer. Helping to push this research along is the fact it’s relatively cost-effective, which is helpful in terms of meeting funding goals.

    Gene Editing Technology Is Offering New Developments

    For those involved in preclinical research and clinical gene therapy, it is incredibly important to have precise genome editing. In a nutshell, gene editing means researchers can change the DNA in an organism, so you can understand just how exciting and promising that can be.

    Much of the research being done in this field right now focuses on cardiovascular diseases, viral infections, and metabolic disorders to name a few. This Cas-CLOVER gene-editing technology shows just how far things have come, and is helping researchers explore all kinds of potential solutions.

    Women’s Health Issues are Getting Attention

    Many women would argue that health issues affecting them have largely gone under-researched and under-acknowledged, which makes many excited to see the progress taking place. There is currently research being done on non-hormonal alternatives for menopause and postpartum depression treatment.

    Statistics from the National Library of Medicine show that approximately one in seven women may develop PPD (postpartum depression). It can vary in severity and duration, and many currently go undiagnosed. When it comes to menopause, for many women, hormone therapy is a safe and recommended treatment option – but it isn’t right for everyone. And considering the negative symptoms of menopause and how impactful they can be, women are searching for help.

    Many Other Developments in the Pipeline

    This is just a small look at the many developments taking place in medical research in the US right now. It’s an exciting time to be a researcher, scientist, or working in the medical industry as a whole, as these developments offer glimmers of promise and hope.

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    nps
    • Website

    Related Content

    Ursula von der Leyen - Antonio Costa -Ahmed al-Sharaa - Photo © European Union 2026

    Brussels proposes full resumption of EU-Syria Cooperation Agreement

    Trader

    Is the Euro Entering a Sustainable Recovery or Still Trapped Between Inflation and Growth Risk?

    EU agenda - Image by Andreas Lischka from Pixabay

    EU Agenda: Week Ahead – 13-18 April 2026

    Euro coins and notes - Photo by Pixabay

    Eurozone Economic Calendar

    Personal training

    The UK’s Musculoskeletal Crisis Is Costing the NHS Billions: Why Specialists Say Prevention Through Exercise Is the Answer

    Population commuters - Image by Pexels from Pixabay

    EU’s population projected to drop by 11.7pct by 2100

    LATEST EU NEWS
    Ursula von der Leyen - Antonio Costa -Ahmed al-Sharaa - Photo © European Union 2026

    Brussels proposes full resumption of EU-Syria Cooperation Agreement

    20 April 2026
    Population commuters - Image by Pexels from Pixabay

    EU’s population projected to drop by 11.7pct by 2100

    16 April 2026
    Google search - Photo by Firmbee.com on Unsplash

    Google must share search data with competitors, says EU

    16 April 2026
    BEAK UAV drone made by Origin Robotics - Photo by Gints Ivuskans © European Union 2025

    EU spends EUR 1.07 bn on 57 defence projects supporting European Readiness Flagships

    15 April 2026
    O'Sullivan - Minzatu - Photo © European Union 2026

    EU and UK take decisive step towards Erasmus+ association in 2027

    15 April 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?